Japan provides a huge market for pharmaceuticals as the second-largest consumer of prescription drugs after the United States and is a massive importer of prescription drugs.
Along with the huge growth potentials of pharmaceutical industry, Japan is also one of the few countries that have strong research and development capabilities for new drugs, and therefore the contribution of the Japanese pharmaceutical industry in promoting global public health is large.
Even with the devastating aftershocks of the 2011 earthquake, Japan managed to resume economic production and the pharmaceutical industry showed it has been built on a solid foundation.
According to some analysts, an interesting trend in Japan pharma right now is that of pro-active globalization, in which Japanese companies are actively examining the possibilities of opening up and expanding into other markets, particularly developing markets. Japan pharma is becoming more global, not only by entering into new markets, but also by adopting more innovative strategies and making investments in subsidiaries previously set up in other Asian countries.
In this context , Pharma Japan, Asia’s leading international trade show which specialises in pharmaceutical ingredients, including APIs, intermediates, additives, functional ingredients, natural extracts, fine chemicals presents significant opportunity for companies looking to increase their business.
The show will be held between June 27 and June 29, 2012 at the Tokyo Big Sight. Alongwith this the 25th edition of Interphex Japan will provide a complete view of pharmaceuticals, life science and drug discovery, to cosmetic R&D and product planning.
Pharmaceutical Ingredients Japan will be an international trade show that will exhibit pharmaceutical ingredients including APIs, intermediates, additives, functional ingredients, natural extracts, fine chemicals, etc. Since it is being held in conjunction with a related event known as Interphex Japan, the visitors will be able to learn a lot about the whole process of pharmaceutical production.
The event will display products and technologies and will provide a grand opportunity to interact face-to-face with potential partners and seek for new business opportunities. Pharmaceutical Ingredients Japan will attract more than 75,000 visitors and it is 12 per cent increase than the attendance which was in the previous year
Pharmaceutical Ingredients Japan will attract a large number of visitors including cosmetic producers, intermediates producers, custom synthesis producers, original molecule designers, generic producers, OTC producers, research institutions and regulatory institutions. The visitors will also include top executives and decision makers from marketing & sales, purchasing, production, R&D, quality control, engineering and management departments.
The event will include participation of lots of exhibitors from all around the world. The exhibitors will include manufacturers, engineers, suppliers, dealers and all other professionals associated with the pharmaceutical industry; they can belong to departments like production, quality control, management, research and development; and marketing & sales. The various exhibiting products include APIs, antibodies, enzymes, synthetic substances, antibiotics, fine chemicals, additives and excipients such as antimicrobial preservatives, emulsifying, flavours, ointments bases, suppository agents and tablet disintegrants.
At the same time Interphex Japan, Asia's largest pharmaceutical event, attracting industry professional from all over the globe includes a technical conference with various seminars for enhancing knowledge on the latest trends in the pharmaceutical industry.
Interphex Japan will be the best event for those who are seeking the latest information pertaining to pharmaceutical industry. The professionals of pharmaceutical industry linked to manufacturing technology, R & D, product quality control, factory control, purchasing / facilities, Information Technology and lots more.
Interphex Japan will be beneficial for all the participants as they will be able to see actual products and technologies, meet face-to-face with potential partners, find solutions to a visitors need and requirements and many more. The manufacturers of this industry will demonstrate their latest products and services before the target audiences.
At the venue, business meetings will be held between professionals of pharmaceutical manufacturers and exhibitors from all over the world. The concurrently held "Technical Conference" having a large number of sessions/seminars which will also attract a large number of attendees , is an ideal place for enhancing knowledge on the latest trends in the pharmaceutical industry.
The vast exhibition centre is gearing up to display a range of advanced and latest equipment used by the pharma industry. For the benefit of the visitors, the expo has set aside dedicated zones. These cover: materials process zone, process inspection/testing equipment zone, suppliers and transfer zone, laboratory measurement analysis equipment zone, biopharma zone, plant engineering zone, water production/control zone, IT solution zone, sterilising equipment & clean room zone, logistics zone and contract services zone. Under pharma packaging, the segments for display are packaging materials and containers.
According to the organisers,the last edition of the event was held successfully, with 1,016 exhibitors. New products/technologies were announced and demonstrations were held in exhibitors' booths. Many business meetings were conducted among exhibitors and visitors. The exhibitors achieved successful show results. Technical sessions including keynote session attracted 3,945 industry professionals.
With a population ageing faster than in other major developed countries, Japan welcomes development of new drugs, devices, and technologies superior to those being created elsewhere. Creating a healthy market and receiving even more attention as a growth market for interested companies serve as a model for other developed countries.
The government and ministry of health and labour welfare has sought to increase generic drugs usage to around 30 per cent in 2012. From the experience of other countries, this would imply a sales value level of roughly 10 per cent, should the volume target be reached. The Japan Generic Medicines Association estimates that generic drugs sales accounted for just under 10 per cent of pharmaceutical sales by value and nearly a quarter of pharmaceutical sales by volume in 2011.
The Japanese government is working to build prompt and effective assessment systems to measure the innovativeness of drugs and medical devices. This increasingly positive environment encourages foreign companies to place high priority on Japan’s pharmaceutical and medical device market and aggressively bring their cutting-edge drugs, devices, and technologies into this market.
Further, the Japanese government introduced an integrated package called the “5-Year Strategy for the Creation of Innovative Pharmaceuticals and Medical Devices.” The plan called for concentrated financing of R&D, development of venture businesses, improving the environment for clinical trials, increasing tie-ups with other Asian countries, speed-up and improvement of quality of review, and also an appropriate recognition of innovative products. Behind this five-year plan is the determination to speedily deliver globally superior drugs, devices, and technologies to Japanese patients and to create an environment that allows product development simultaneously with the US and Europe, according to the Japan External Trade Organisation (JETRO).